Bioprocessing

Scotland flag
#Bioprocessing #Biotechnology #Cell line development #Financing #uFraction8

Scottish biotech company secures £3.4m investment

uFraction8 has secured £3.4 ($4.2) million in new investment following the completion of a funding round led by Foresight Group.  Based in Falkirk with a fully-owned subsidiary in Poland, uFraction8’s microfiltration technology is designed to optimise cell and biomass production, offering a sustainable, energy-efficient alternative to traditional… Read More

#Business & Investment #News

Monoclonal antibody
#Bioprocessing #Drug discovery #Monoclonal antibodies #Sustainability

How single-use technologies can improve antibodies production  

DDW Editor Reece Armstrong speaks to David Chau, Global Bioprocess Application Specialist, Purification and Filtration Business, Solventum, formerly 3M Health Care, about challenges in producing monoclonal antibodies (mAbs) and how single-use technologies can simplify processes.   RA: What are some of the current limitations for producing… Read More

#Exclusive Content

Scientist and bioreactor
#Bioprocessing #Bioreactor #LC-MS #Sample preparation #Waters Corporation

New system allows data acquisition straight from the reactor

Waters Corporation has launched new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis. By eliminating the need to send bioreactor samples to a central laboratory for analysis, the company believes the new solutions make it easier to accelerate upstream bioprocess development by… Read More

#News

Digital bioprocessing
#Bioprocessing #Culture Biosciences #Cytiva #Digitalisation #In Silico Biology

Collaboration seeks to advance upstream bioprocessing 

Culture Biosciences and Cytiva are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and robust scale-up capabilities.   Together, the companies aim to bring new bioprocess solutions to customers that use digitaliation, in-silico approaches, and virtual monitoring and control of experiments. … Read More

#News

#Advertorial #Astrea Bioseparations #Bioprocessing #Cell and gene therapy #Nanofiber technology

Nanofiber technology enabling the future of CGT bioprocessing

This paid-for advertorial by Astrea Bioseparations appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 – Cell and Gene Therapy Guide. Therapeutic developers face significant challenges in purifying cell and gene therapy (CGT) modalities. Current processes rely on solutions developed for monoclonal antibodies that are not fit for purpose… Read More

#Exclusive Content